Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Goldman Strikes Deal to Buy LCN to Become Hands-Off Landlord
Bloomberg's Katherine Chiglinsky joins Dani Burger on "Bloomberg Deals." Goldman Sachs struck its second deal in a week as the firm pushes ahead with plans to grow its $4 trillion money-management…
Kaplan Fox Reminds UWM Holdings Corporation (NYSE: UWMC) Investors with Significant Losses to Seek a Leadership Role Before Deadline on October 13, 2026
NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation (“UWM Holdings” or the “Company”) (NYSE…
NGX sheds N555 billion as Aradel plunge deepens seven-day market slide
The Nigerian equities market extended its decline on Wednesday, August 19, 2026, with the All-Share Index (ASI) falling for a seventh consecutive trading session, as renewed selling pressure in oil…
This Billionaire Tech Investor Is Betting Big on SpaceX and Chip Stocks
Philippe Laffont aggressively added to his positions in semiconductor stocks in the second quarter.
BoG’s US$1.7bn Domestic Gold Purchase programme not our loss – Goldbod
The Chief Executive Officer of the Ghana Gold Board (GoldBod), Sammy Gyamfi, has drawn a clear distinction between GoldBod’s financial performance and the US$1.7 billion loss recorded by the Bank of…